Literature DB >> 12234865

In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.

Niki I Paphitou1, Luis Ostrosky-Zeichner, Victor L Paetznick, Jose R Rodriguez, Enuo Chen, John H Rex.   

Abstract

We studied the effects of inoculum size and incubation time on the susceptibility testing results for various antifungal agents against 22 Fusarium isolates by the NCCLS microdilution method. Increased inoculum size and extended incubation time resulted in elevated MICs. Posaconazole and voriconazole exhibited promising antifungal activities.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12234865      PMCID： PMC128790          DOI： 10.1128/AAC.46.10.3298-3300.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Antifungal drug resistance in Aspergillus.

Authors:  C B Moore; N Sayers; J Mosquera; J Slaven; D W Denning
Journal:  J Infect       Date:  2000-11       Impact factor: 6.072

2.  Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole.

Authors:  A Reis; R Sundmacher; K Tintelnot; H Agostini; H E Jensen; C Althaus
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

Review 3.  The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme.

Authors:  C Girmenia; L Pagano; L Corvatta; L Mele; A del Favero; P Martino
Journal:  Br J Haematol       Date:  2000-10       Impact factor: 6.998

4.  In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

Authors:  Sevtap Arikan; Mario Lozano-Chiu; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.

Authors:  A L Barry; M A Pfaller; S D Brown; A Espinel-Ingroff; M A Ghannoum; C Knapp; R P Rennie; J H Rex; M G Rinaldi
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; S Nangia; J H Rex
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years.

Authors:  M O Musa; A Al Eisa; M Halim; E Sahovic; M Gyger; N Chaudhri; F Al Mohareb; P Seth; M Aslam; M Aljurf
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

8.  Treatment of murine fusariosis with SCH 56592.

Authors:  M Lozano-Chiu; S Arikan; V L Paetznick; E J Anaissie; D Loebenberg; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

9.  Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.

Authors:  D W Denning; S A Radford; K L Oakley; L Hall; E M Johnson; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

10.  In vitro activity of a new oral triazole, BMS-207147 (ER-30346)

Authors:  J C Fung-Tomc; E Huczko; B Minassian; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191
View more
  23 in total

1.  What's New in Antifungals?

Authors:  John M. Valgus
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

2.  Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.

Authors:  A Espinel-Ingroff; A Fothergill; M Ghannoum; E Manavathu; L Ostrosky-Zeichner; M Pfaller; M Rinaldi; W Schell; T Walsh
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex.

Authors:  Mónica Azor; Josepa Gené; Josep Cano; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

4.  Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.

Authors:  A J Ullmann; O A Cornely; A Burchardt; R Hachem; D P Kontoyiannis; K Töpelt; R Courtney; D Wexler; G Krishna; M Martinho; G Corcoran; I Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.

Authors:  N Venkatesh Prajna; Prajna Lalitha; Revathi Rajaraman; Tiruvengada Krishnan; Anita Raghavan; Muthiah Srinivasan; Kieran S O'Brien; Michael Zegans; Stephen D McLeod; Nisha R Acharya; Jeremy D Keenan; Thomas M Lietman; Jennifer Rose-Nussbaumer
Journal:  JAMA Ophthalmol       Date:  2016-06-01       Impact factor: 7.389

6.  Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.

Authors:  A Debourgogne; S de Hoog; A Lozniewski; M Machouart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-09       Impact factor: 3.267

Review 7.  Pharmacokinetic/pharmacodynamic profile of posaconazole.

Authors:  Yanjun Li; Ursula Theuretzbacher; Cornelius J Clancy; M Hong Nguyen; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

8.  Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases.

Authors:  Graziella Hanna Pereira; Derlene Attili de Angelis; Roosecelis Araujo Brasil; Marilena dos Anjos Martins; Dulcilena de Matos Castro e Silva; Maria Walderez Szeszs; Marcia de Souza Carvalho Melhem
Journal:  Mycopathologia       Date:  2012-10-18       Impact factor: 2.574

9.  Pentamidine is active in vitro against Fusarium species.

Authors:  Michail S Lionakis; Russell E Lewis; George Samonis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 10.  Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

Authors:  Helen W Boucher; Andreas H Groll; Christine C Chiou; Thomas J Walsh
Journal:  Drugs       Date:  2004       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.